Copyright Reports & Markets. All rights reserved.

Global Soliris (Eculizumab) Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Soliris (Eculizumab) by Type
    • 1.3.1 Overview: Global Soliris (Eculizumab) Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Soliris (Eculizumab) Consumption Value Market Share by Type in 2025
    • 1.3.3 Plasma Exchange
    • 1.3.4 Plasma Infusion
  • 1.4 Global Soliris (Eculizumab) Market by Application
    • 1.4.1 Overview: Global Soliris (Eculizumab) Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 PNH
    • 1.4.3 aHUS
    • 1.4.4 Others
  • 1.5 Global Soliris (Eculizumab) Market Size & Forecast
  • 1.6 Global Soliris (Eculizumab) Market Size and Forecast by Region
    • 1.6.1 Global Soliris (Eculizumab) Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Soliris (Eculizumab) Market Size by Region, (2021-2032)
    • 1.6.3 North America Soliris (Eculizumab) Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Soliris (Eculizumab) Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Soliris (Eculizumab) Market Size and Prospect (2021-2032)
    • 1.6.6 South America Soliris (Eculizumab) Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Soliris (Eculizumab) Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Alexion
    • 2.1.1 Alexion Details
    • 2.1.2 Alexion Major Business
    • 2.1.3 Alexion Soliris (Eculizumab) Product and Solutions
    • 2.1.4 Alexion Soliris (Eculizumab) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Alexion Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Soliris (Eculizumab) Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Soliris (Eculizumab) by Company Revenue
    • 3.2.2 Top 3 Soliris (Eculizumab) Players Market Share in 2025
    • 3.2.3 Top 6 Soliris (Eculizumab) Players Market Share in 2025
  • 3.3 Soliris (Eculizumab) Market: Overall Company Footprint Analysis
    • 3.3.1 Soliris (Eculizumab) Market: Region Footprint
    • 3.3.2 Soliris (Eculizumab) Market: Company Product Type Footprint
    • 3.3.3 Soliris (Eculizumab) Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Soliris (Eculizumab) Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Soliris (Eculizumab) Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Soliris (Eculizumab) Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Soliris (Eculizumab) Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Soliris (Eculizumab) Consumption Value by Type (2021-2032)
  • 6.2 North America Soliris (Eculizumab) Market Size by Application (2021-2032)
  • 6.3 North America Soliris (Eculizumab) Market Size by Country
    • 6.3.1 North America Soliris (Eculizumab) Consumption Value by Country (2021-2032)
    • 6.3.2 United States Soliris (Eculizumab) Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Soliris (Eculizumab) Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Soliris (Eculizumab) Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Soliris (Eculizumab) Consumption Value by Type (2021-2032)
  • 7.2 Europe Soliris (Eculizumab) Consumption Value by Application (2021-2032)
  • 7.3 Europe Soliris (Eculizumab) Market Size by Country
    • 7.3.1 Europe Soliris (Eculizumab) Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Soliris (Eculizumab) Market Size and Forecast (2021-2032)
    • 7.3.3 France Soliris (Eculizumab) Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Soliris (Eculizumab) Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Soliris (Eculizumab) Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Soliris (Eculizumab) Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Soliris (Eculizumab) Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Soliris (Eculizumab) Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Soliris (Eculizumab) Market Size by Region
    • 8.3.1 Asia-Pacific Soliris (Eculizumab) Consumption Value by Region (2021-2032)
    • 8.3.2 China Soliris (Eculizumab) Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Soliris (Eculizumab) Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Soliris (Eculizumab) Market Size and Forecast (2021-2032)
    • 8.3.5 India Soliris (Eculizumab) Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Soliris (Eculizumab) Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Soliris (Eculizumab) Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Soliris (Eculizumab) Consumption Value by Type (2021-2032)
  • 9.2 South America Soliris (Eculizumab) Consumption Value by Application (2021-2032)
  • 9.3 South America Soliris (Eculizumab) Market Size by Country
    • 9.3.1 South America Soliris (Eculizumab) Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Soliris (Eculizumab) Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Soliris (Eculizumab) Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Soliris (Eculizumab) Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Soliris (Eculizumab) Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Soliris (Eculizumab) Market Size by Country
    • 10.3.1 Middle East & Africa Soliris (Eculizumab) Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Soliris (Eculizumab) Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Soliris (Eculizumab) Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Soliris (Eculizumab) Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Soliris (Eculizumab) Market Drivers
  • 11.2 Soliris (Eculizumab) Market Restraints
  • 11.3 Soliris (Eculizumab) Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Soliris (Eculizumab) Industry Chain
  • 12.2 Soliris (Eculizumab) Upstream Analysis
  • 12.3 Soliris (Eculizumab) Midstream Analysis
  • 12.4 Soliris (Eculizumab) Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Soliris (Eculizumab) market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.
    In Asia-Pacific, Japan is the largest Soliris (Eculizumab) market with about 32% market share. China is follower, accounting for about 25% market share.The key manufacturers are Alexion etc.
    This report is a detailed and comprehensive analysis for global Soliris (Eculizumab) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Soliris (Eculizumab) market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Soliris (Eculizumab) market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Soliris (Eculizumab) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Soliris (Eculizumab) market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Soliris (Eculizumab)
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Soliris (Eculizumab) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alexion, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Soliris (Eculizumab) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Plasma Exchange
    Plasma Infusion
    Market segment by Application
    PNH
    aHUS
    Others
    Market segment by players, this report covers
    Alexion
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Soliris (Eculizumab) product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Soliris (Eculizumab), with revenue, gross margin, and global market share of Soliris (Eculizumab) from 2021 to 2026.
    Chapter 3, the Soliris (Eculizumab) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Soliris (Eculizumab) market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Soliris (Eculizumab).
    Chapter 13, to describe Soliris (Eculizumab) research findings and conclusion.

    Buy now